'Profiteering during health emergency is inhuman': Mayawati slams Punjab govt over selling COVID-19 vaccine

-

Lucknow: Bahujan Samaj Party (BSP) chief Mayawati on Saturday hit out at the Congress-led Punjab government for allegedly selling COVID-19 vaccine doses procured under the state quota to private hospitals at a higher rate, saying profiteering during an emergency is "indecent and inhuman".

Follow LIVE updates on COVID-19 here

Her remarks came a day after the Punjab government asked private hospitals to return all vaccine stock meant for the 18-44 age group and ordered a probe into the allegations.

The recalled vaccine doses will be administered free to this age group by the government, state Health Minister Balbir Singh Sidhu said.

In a tweet in Hindi, Mayawati said, "The Congress government of Punjab is buying COVID-19 vaccines at Rs 400 (each) from the Centre and selling them to private hospitals at Rs 1,060 instead of passing on the benefits to the people through government hospitals. Profiteering during an emergency is indecent, inhuman, condemnable and extremely saddening."

"This makes it clear that the Congress' stand and statements on vaccines so far lacked seriousness. The BSP demands that the Centre take cognisance of this," she said.

Referring to media reports, Union Minister and senior BJP leader Prakash Javadekar had on Friday alleged the Punjab government got over 1.40 lakh doses of Covaxin at Rs 400 each and gave some of them to 20 private hospitals at Rs 1,000 each.

This is "dangerous" news, he had said.

The Centre has also written to the Punjab government seeking a clarification over reports that it sold Covaxin to private hospitals and earned a profit.



from Firstpost India Latest News https://ift.tt/3z6oU6M
Press Trust of India

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

120 flights delayed, 30 trains running late; Delhi fog & cold wave continue to give shiver to travellers

-
Arrival and departure of 120 flights, both domestic and international, to Delhi airport were affected due to dense fog and cold wave conditions on Wednesday, according to Delhi Airport FIDS (Flight Information Display System). As per the Delhi Airport FIDS, a total of 53 flights, including 21 domestic arrivals, 16 domestic departures, 13 international departures and three international arrivals scheduled are cancelled and not operating due to fog and other operational reasons from and to Indira Gandhi International (IGI) Airport in the national capital on 17 January. #WATCH | Delhi: Several flight operations delayed at IGI airport due to low visibility amid fog. pic.twitter.com/hG1DUKllEt — ANI (@ANI) January 17, 2024 Visuals from the Delhi airport showed passengers waiting outside, checking update of their scheduled flights. There were also some people waiting for flight of their families, friends and loved ones to arrive, which got delayed due to fog. #WATCH | Delhi | Pas
Read more